Morshed, R A
Gutova, M
Juliano, J
Barish, M E
Hawkins-Daarud, A
Oganesyan, D
Vazgen, K
Yang, T
Annala, A http://orcid.org/0000-0002-5967-6596
Ahmed, A U
Aboody, K S
Swanson, K R
Moats, R A
Lesniak, M S
Article History
Received: 22 October 2014
Revised: 20 November 2014
Accepted: 21 November 2014
First Online: 19 December 2014
Competing interests
: AJA and KSA are share-holders, directors and officers of TheraBiologics, a clinical stage biopharmaceutical company focused on the development of stem cell-mediated cancer therapy. RAM is a director of TheraBiologics.